Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a

OBJECTIVE: Evaluate the effect of subcutaneous interferon β-1a (sc IFN β-1a) versus placebo on the evolution of T1-weighted MRI lesions and central brain atrophy in in patients with a first clinical demyelinating event (FCDE). METHODS: Post hoc analysis of baseline-to-24 month MRI data from patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Vrenken, H., Battaglini, M., de Vos, M. L., Nagtegaal, G. J., Teixeira, B. C. A., Seitzinger, A., Jack, D., Sormani, M. P., Uitdehaag, B. M. J., Versteeg, A., Comi, G., Kappos, L., De Stefano, N., Barkhof, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025187/
https://www.ncbi.nlm.nih.gov/pubmed/36723685
http://dx.doi.org/10.1007/s00415-022-11554-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025187/
https://www.ncbi.nlm.nih.gov/pubmed/36723685
http://dx.doi.org/10.1007/s00415-022-11554-5

Ejemplares similares